MoneyWorks4Me

Dr Reddys Laboratories informs about disclosure

28 Jul 2021 Evaluate
Dr Reddys Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended June 30, 2021, with the United States Securities and Exchange Commission on July 27, 2021. A copy of the Form 6- K is attached.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..